Sentences with phrase «global product development at»

The Verge quotes Shakil Barkat, head of global product development at Moto as saying, «Wearables do not have broad enough appeal for us to continue to build on it year after year.»

Speaking to The Verge, head of Global Product Development at Motorola and Lenovo's mobile group Shakil Barkat noted that there isn't «enough pull in the market to put [a new smartwatch] out at this time.»

Motorola doesn't «see enough pull in the market» to launch a new smartwatch, Shakil Barkat, head of global product development at the company, told The Verge.

Not too long ago, The Verge managed to get some time with Shakil Barkat, Head of Global Product Development at Motorola, when he told the Verge that, «Wearables do not have broad enough appeal for us to continue to build on it year after year».

Guests include Reid Bigland who talks about his brand's just - unveiled Dodge Dart; Mary Barra, the Senior VP of Global Product Development at GM, with some thoughts about Chevy's set of provoking concepts; and Ludwig Willisch, the President of BMW North America, who says the company's i concepts are very close to what you'll see in production.

Gabrielle Nevin, the vice president of global product development at the cosmetics company, explained to Allure that most of the foundation's 30 hues have more yellow pigments in them because most people have yellow or green tones in their skin and want any redness canceled out.»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

«To get the true value, you need the network effect,» said Graham Warner, head of global transaction banking product development in the Americas at Deutsche Bank, told Business Insider in 2016.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

«Autonomous vehicle technology is another step closer to production at Ford,» said Raj Nair, Ford's group vice president for global product development.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Before Facebook, Mike was vice president of engineering at Mozilla Corporation, where he led the global and open product development process behind Firefox.

Julie Winkler, Senior Managing Director, Research, Product Development and Index Services at CME Group said, «Developing a digital gold trading platform will help ensure that CME Group's current product offerings meet the evolving needs of the global markeProduct Development and Index Services at CME Group said, «Developing a digital gold trading platform will help ensure that CME Group's current product offerings meet the evolving needs of the global markeproduct offerings meet the evolving needs of the global marketplace.

Prior to joining Venzee in 2017, he was Managing Director at Websky Ltd. (Expert Agent) from 2003 to 2012, and from 2014 to 2015 Chief Operating Officer at PDT Technologies Inc., a global, full - service product design and development firm that is now called Kabuni Ltd., and is traded on the Australian Stock Exchange.

Isabelle Maddock, finance director at James Cropper, adds: «The global market continues to be essential for growth and development, with about 50 per cent of our products being exported.

SCOTTSDALE, Ariz., May 5, 2016 / PRNewswire / — RiceBran Technologies (NASDAQ: RIBT and RIBTW)(the «Company» or «RBT»), a global leader in the production and marketing of value added products derived from rice bran, announced today that it has entered into two agreements: a Memorandum of Understanding (MOU) with non-profit The Jack Brewer Foundation (JBF Worldwide) to develop rice bran based supplemental feeding programs currently assisted by JBF Worldwide at orphanages in Malawi and Haiti; and a business development agreement with Brewer + Associates Consulting, LLC (B+A) to collaborate on the planned launch of a new line of sports nutrition products with a portion of profits earmarked to provide rice bran based meal supplements for feeding programs covered by the MOU.

«With casual dining on the rise, our guests can enjoy quick, healthy and gourmet food options at value - driven prices,» said Beth Scott, vice president, global product development, food & beverage, Hilton Worldwide.

With the harvested follicles, investigators such as James V. («Vince») Gruber, global director of research and development at Lonza Consumer Care, can test the effectiveness of new hair and skin products without relying on laboratory animals.

«Biofortified crops have been released in 60 countries,» said Wolfgang Pfeiffer, HarvestPlus global director for product development and commercialization, speaking at the conference.

He has been involved in the development of the Soochika, StrandNGS and GeneSpring products at Strand as well as managing global support for all of Strand's computation products.

Prior to founding Pappas Capital, Art held senior level leadership positions at several multinational pharmaceutical companies for which he was responsible for the development, licensing and launch of a number of global products.

The development at Gaydon, 90 miles northwest of London, is intended to become one of the world's foremost automotive product, engineering and design sites, underscoring the automaker's plans for global growth.

Mark Reuss, GM's global product chief, recently confirmed Cadillac is looking at an entry - level competitor, while Leone, who also heads up development of rear - wheel - drive cars at GM, is categorical in saying the brand does not want a front - wheel - drive car at the base of its lineup.

We asked Fords Vice President of Engineering for Global Product Development, Hau Thai - Tang seven questions at the Chicago show.

«The Corvette ZR1's lap record at VIR, arguably America's most challenging road course, is a testament to its supercar status,» said Mark Reuss, executive vice president, Global Product Development, Purchasing and Supply Chain.

Ford is still the largest global shareholder at 11 percent and maintains a close product - development relationship.

At the launch event, Mark Reuss, GM's executive vice president of global product development, remarked: «These cars reflect a completely different philosophical approach to how we engineer our vehicles.»

Prior to that, Atkinson was head of business development for the exchange - traded products business at Barclays Global Investors Canada Ltd., now iShares; he has also held positions with a national investment dealer and major mutual fund companies.

Most recently, as Head of Global Small Business for Visa Inc, Zablock directed the development and implementation of the strategic vision for Visa Business products targeted at the small business market segment.

He has held global strategic planning, product development, and marketing roles at major financial services companies including American Express Company, Visa International and Charles Schwab & Co., Inc..

After unveiling the new offerings at the brand's North American Convention, the International Hotel Investment Forum (IHIF) in Berlin is the first opportunity for international developers and investors to see and learn about the brand's global development strategy for these two new hotel products.

Charles Hall has been named Senior Product Manager at Generali Global Assistance's Travel Insurance division, where he is responsible for product planning and development to bring innovative travel insurance products to the consumer, retail, and vacation rental marketProduct Manager at Generali Global Assistance's Travel Insurance division, where he is responsible for product planning and development to bring innovative travel insurance products to the consumer, retail, and vacation rental marketproduct planning and development to bring innovative travel insurance products to the consumer, retail, and vacation rental marketplaces.

Former senior director of global community development and eSport at Blizzard, Paul Della Bitta is Molten's chief product officer.

Abdulmalik Ali is an Associate Programme Officer at the International Renewable Energy Agency (IRENA) where he supports the development of an internet based Global Atlas for Renewable Energy, which is the world's largest globally accessible geographic information product dedicated to promoting prospective areas for renewable energy development all over the world.

Before Facebook, Mike was vice president of engineering at Mozilla Corporation, where he led the global and open product development process behind Firefox.

Combined with my team of expert resume writers and coaches, we've supported clients in some of the following industries and categories: fashion, technology, IT, startups, global business, education, social services, finance, non-profit, marketing, product development, entry - level, millennials, mid-level, executives, aspiring executives, women, stay - at - home moms returning to the workforce, women seeking promotions, professionals in transition, brand transformations, military, healthcare, career changers and more.

Profile: Global Sourcing / Production / Product Development Expertise in managing a global sourcing and product development Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in sales and Global Sourcing / Production / Product Development Expertise in managing a global sourcing and product development Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in sales andProduct Development Expertise in managing a global sourcing and product development Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in salesDevelopment Expertise in managing a global sourcing and product development Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in sales and global sourcing and product development Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in sales andproduct development Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in salesdevelopment Summary: Comprehensive experience in strategic direction of product development, sourcing, and operations of brands valued at $ 500 million in sales andproduct development, sourcing, and operations of brands valued at $ 500 million in salesdevelopment, sourcing, and operations of brands valued at $ 500 million in sales and above.

Involved throughout the product development cycle, product launch, training, and outbound product marketing at a US Region and Global level.

Talented business / product development, strategy and marketing executive with demonstrated success at delivering revenue - generating results by creating and expanding product and business lines, closing deals, launching global products and services, growing mature products and brands and creating strategic partnerships and alliances in consumer and commercial markets.

ADDITIONAL EXPERIENCE (Details available upon request) • Director, Market Development and Solutions Engineering; Manager, Global Product Management; Manager, Market Development; Manager, Global Product Management & Sales Systems Engineering at Lucent Technologies / AT&T Network Systems, Location • Product Management at AT&T Medical Ventures / Philips Medical Systems, Location • Chief Biomedical Engineer at Berlex Laboratories, Inc., Location

Prior to joining Lazard in 2011, Christopher was Senior Advisor at Grubb & Ellis Alesco Global Advisors, responsible for alternative investment strategies, capital markets, product development and research.